Simulations Plus Operating Income 2010-2025 | SLP
Simulations Plus operating income from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Simulations Plus Annual Operating Income
(Millions of US $) |
| 2024 |
$6 |
| 2023 |
$9 |
| 2022 |
$15 |
| 2021 |
$11 |
| 2020 |
$12 |
| 2019 |
$11 |
| 2018 |
$10 |
| 2017 |
$8 |
| 2016 |
$7 |
| 2015 |
$6 |
| 2014 |
$4 |
| 2013 |
$4 |
| 2012 |
$4 |
| 2011 |
$4 |
| 2010 |
$3 |
| 2009 |
$2 |
Simulations Plus Quarterly Operating Income
(Millions of US $) |
| 2025-02-28 |
$3 |
| 2024-11-30 |
$0 |
| 2024-08-31 |
$-1 |
| 2024-05-31 |
$2 |
| 2024-02-29 |
$4 |
| 2023-11-30 |
$1 |
| 2023-08-31 |
$0 |
| 2023-05-31 |
$4 |
| 2023-02-28 |
$4 |
| 2022-11-30 |
$1 |
| 2022-08-31 |
$1 |
| 2022-05-31 |
$5 |
| 2022-02-28 |
$5 |
| 2021-11-30 |
$4 |
| 2021-08-31 |
$0 |
| 2021-05-31 |
$5 |
| 2021-02-28 |
$3 |
| 2020-11-30 |
$3 |
| 2020-08-31 |
$2 |
| 2020-05-31 |
$4 |
| 2020-02-29 |
$3 |
| 2019-11-30 |
$3 |
| 2019-08-31 |
$2 |
| 2019-05-31 |
$4 |
| 2019-02-28 |
$3 |
| 2018-11-30 |
$2 |
| 2018-08-31 |
$2 |
| 2018-05-31 |
$3 |
| 2018-02-28 |
$2 |
| 2017-11-30 |
$3 |
| 2017-08-31 |
$1 |
| 2017-05-31 |
$3 |
| 2017-02-28 |
$2 |
| 2016-11-30 |
$2 |
| 2016-08-31 |
$1 |
| 2016-05-31 |
$3 |
| 2016-02-29 |
$2 |
| 2015-11-30 |
$2 |
| 2015-08-31 |
$1 |
| 2015-05-31 |
$3 |
| 2015-02-28 |
$1 |
| 2014-11-30 |
$1 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$2 |
| 2014-02-28 |
$1 |
| 2013-11-30 |
$1 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$2 |
| 2013-02-28 |
$2 |
| 2012-11-30 |
$1 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$1 |
| 2012-02-29 |
$1 |
| 2011-11-30 |
$1 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$1 |
| 2011-02-28 |
$1 |
| 2010-11-30 |
$1 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$1 |
| 2010-02-28 |
$1 |
| 2009-11-30 |
$1 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$1 |
| 2009-02-28 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.352B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
